Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SQM | LIN |
|---|---|---|
| Price | $63.64 | $465.76 |
| Change today | ▼ 1.90% | ▼ 1.87% |
| Market cap | $18.18B | $214.71B |
| Return, 3 months | -12.6% | -12.4% |
| Return, year to date | -4.7% | +10.3% |
| Return, 1 year | +51.0% | +1.1% |
| P/E (TTM) | 13.1 | 30.0 |
| P/B | 2.9 | 5.5 |
| P/E percentile vs own 5y | – | 5th |
| Dividend yield | 1.62% | 1.33% |
| Revenue growth (YoY, latest qtr) | – | +9.3% |
| Net profit growth (YoY) | – | +9.2% |
| Gross margin | – | 48.3% |
| Operating margin | – | 27.1% |
| Net margin | – | 20.4% |
| Return on equity | – | 18.7% |
| Analyst target vs. price | +39.9% | +19.7% |
| Analyst buy share | 57% | 87% |
| RSI (14) | 35 | 52 |
| 30-day volatility | 42.0% | 13.1% |
| Max drawdown, 1 year | -30.1% | -18.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
